Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

dantrolene

dantrolene
Drug Name Form Strength Notes
Dantrolene CAPSULE, ORAL 25 mg
Dantrolene CAPSULE, ORAL 50 mg
Dantrolene CAPSULE, ORAL 100 mg
Revonto POWDER FOR INJECTION, INTRAVENOUS 20 mg
Ryanodex SOLUTION, INTRAVENOUS 250 mg per vial


Additional Information:

Malignant Hyperthermia Management: Policy 909.5229

Ryanodex is the Formulary Agent for dantrolene.  See Ryanodex Reconstitution Instructions

If extravasation occurs, please refer to Elsevier Clinical Skills: Prevention and Management of Extravasations for the Treatment and Management of Extravasations


Last updated: Jan. 30, 2025







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.